Advances in immuno-oncology continue to transform cancer treatment, offering hope where traditional therapies have fallen short. However, clinical challenges remain. These challenges include treatment resistance, off-target effects, and the ability of cancer stem cells (CSCs) to promote disease progression. Understanding these challenges is essential for developing more effective immunotherapies.
Join our upcoming webinar where we’ll discuss how advanced research tools are helping scientists understand treatment resistance caused by CSCs. We’ll cover innovative solutions for studying CSCs and their role in treatment resistance, as well as co-culture systems for cancer cells and immune cells.
What you’ll take away from this webinar:
- Innovative tools for isolating and cultivating CSCs
- Co-culture systems for studying cancer cell and immune cell interactions
- Advanced 3D tumor modeling for deeper tumor microenvironment insights
- Safety and precision considerations in adoptive cell therapies
Join our webinar:
Advancing immuno-oncology: Innovative solutions for adoptive cell therapy
Thursday, October 16th, 1:00-2:00 PM EST
This webinar is free and open to the general public, with no Prendio membership required.
Can’t attend live? No problem. We’ll make a recording of the event available on our website and share it via email with those registered.
Featured speaker
Dr. Alexander Trampe
Scientific Support Specialist | Project Manager
Dr. Alexander Trampe brings over a decade of scientific expertise to this discussion. After studying biochemistry at the University of Bielefeld and completing his PhD in cell biology at the University of Lübeck, Dr. Trampe spent more than 10 years as a Scientific Support Specialist before becoming Project Manager of our Cancer Media Toolbox. This experience allows him to bridge the gap between cutting-edge research and practical laboratory applications.
Explore the future of immuno-oncology research Ready to advance your understanding of adoptive cell therapies?